ChemicalBook > Product Catalog >API >Antibiotics >Other antibiotic Drugs >Mupirocin

Mupirocin

Mupirocin Structure
CAS No.
12650-69-0
Chemical Name:
Mupirocin
Synonyms
MUPIROCIN CALCIUM;231-791-2;PSEUDOMONIC ACID;PSEUDOMONIC ACID A;bactroban;Turixi;Turixin;Mupricin;MUPIROCIN;Bactoderm
CBNumber:
CB0689829
Molecular Formula:
C26H44O9
Molecular Weight:
500.62
MOL File:
12650-69-0.mol
Modify Date:
2024/8/21 22:41:43

Mupirocin Properties

Melting point 77-780C
alpha D20 -19.3° (c = 1 in methanol)
Boiling point 672℃
Density 1.183±0.06 g/cm3(Predicted)
Flash point >110°(230°F)
storage temp. Inert atmosphere,Store in freezer, under -20°C
solubility H2O: 12 mg/mL, soluble
form solid
pka 4.78±0.10(Predicted)
color white to tan
optical activity [α]/D -15.7 to -20°, c = 1 in methanol
Water Solubility Soluble in DMSO or methanol. Sparingly soluble in water
λmax 222nm(EtOH)(lit.)
Merck 14,6302
Stability Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 1 month.
InChIKey MINDHVHHQZYEEK-HBBNESRFSA-N
CAS DataBase Reference 12650-69-0(CAS DataBase Reference)

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H317
Precautionary statements  P261-P280
WGK Germany  2
RTECS  RA6907000
HS Code  2941906000
NFPA 704
0
2 0

Mupirocin price More Price(5)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich(India) PHR2806 Mupirocin pharmaceutical secondary standard 12650-69-0 100MG ₹15490.58 2022-06-14 Buy
Sigma-Aldrich(India) M7694 Mupirocin ≥92% (HPLC), powder 12650-69-0 50MG ₹42585.55 2022-06-14 Buy
Sigma-Aldrich(India) M7694 Mupirocin ≥92% (HPLC), powder 12650-69-0 100MG ₹76651.83 2022-06-14 Buy
TCI Chemicals (India) M2955 Mupirocin 12650-69-0 25MG ₹4300 2022-05-26 Buy
TCI Chemicals (India) M2955 Mupirocin 12650-69-0 100MG ₹13600 2022-05-26 Buy
Product number Packaging Price Buy
PHR2806 100MG ₹15490.58 Buy
M7694 50MG ₹42585.55 Buy
M7694 100MG ₹76651.83 Buy
M2955 25MG ₹4300 Buy
M2955 100MG ₹13600 Buy

Mupirocin Chemical Properties,Uses,Production

Description

Mupirocin (pseudomonic acid A) is an antibiotic produced by Pseudomonas fluorescens. It is useful in the treatment of dermal infections, especially those involving S. aureus and S. epidermidis.

Chemical Properties

White Crystalline Solid

Uses

Mupirocin, is a major component of the pseudomonic acid, an antibiotic complex produced by Pseudomonas fluorescens NCIB 10586. Topical antibacterial.

Indications

Mupirocin (Bactroban, Centany) is a topical antibiotic produced by fermented Pseudomonas fluorescens. It has a narrow spectrum of activity, mostly against gram-positive aerobic bacteria (including Staphylococcus and methicillin-resistant Staphylococcus) and many strains of Streptococcus. It is also active against some gram-negative aerobic bacteria but is inactive against anaerobes, Chlamydia, and fungi. It has proved equal in efficacy in the treatment of impetigo when compared with oral erythromycin, with fewer adverse side effects.
Mupirocin does not interfere with wound healing. It is active only on topical administration and is converted to an inert molecule on systemic administration. Prolonged use of mupirocin increases the risk of evolution of resistant organisms. Themechanism of action has not yet been fully classified, but it does differ from other available antiinfective agents, and there is little chance of cross-resistance developing. Also, unlike many other topical antibiotics, it rarely causes allergic sensitization.

Definition

ChEBI: An alpha,beta-unsaturated ester resulting from the formal condensation of the alcoholic hydroxy group of 9-hydroxynonanoic acid with the carboxy group of (2E)-4-[(2S)-tetrahydro-2 -pyran-2-yl]-3-methylbut-2-enoic acid in which the tetrahydropyranyl ring is substituted at positions 3 and 4 by hydroxy groups and at position 5 by a {(2S,3S)-3-[(2S,3S)-3-hydro ybutan-2-yl]oxiran-2-yl}methyl group. Originally isolated from the Gram-negative bacterium Pseudomonas fluorescens, it is used as a topical antibiotic for the treatment of Gram-positive bacterial infections.

Antimicrobial activity

It is active against staphylococci and streptococci, but also Neisseria and Haemophilus spp. Enterococcus faecalis tends to be sensitive whereas E. faecium is usually resistant. Activity against Staph. aureus is affected by inoculum such that a 10-fold increase in the inoculum causes doubling of the minimum inhibitory concentration (MIC) in vitro. Activity also decreases as pH increases above the normal skin pH of 5.5.

Acquired resistance

Before the introduction of mupirocin, resistance in Staph. aureus was uncommon, with a natural mutation frequency of 1 in 109. However, shortly after the agent was introduced, mupirocin-resistant strains began to emerge. They are of two types: low level (MIC 8–256 mg/mL) and high level (MIC >256 mg/mL).
High-level resistance, in contrast, is linked to the acquisition of a transmissible resistance gene MupA that may co-transfer with other antimicrobial resistance genes. Strains that express MupA are not clinically susceptible to mupirocin.
Several studies suggest that widespread use of prophylactic mupirocin may result in increased levels of resistance. In Canada increasing use of mupirocin across the country led to high-level mupirocin resistance, rising from 1.6% to 7% over a 9-year period.

Pharmaceutical Applications

Mupirocin is an antimicrobial substance originally derived from Pseudomonas fluorescens. It is a mixture of pseudomonic acids with more than 90% of the commercial product being pseudomonic acid A.
It has activity predominantly against Gram-positive bacteria and its main use is as a topical agent for the eradication of carriage of methicillin-resistant Staphylococcus aureus (MRSA). It is also used as a topical treatment for superficial skin infections caused by Grampositive organisms such as impetigo.

Pharmacokinetics

Following parenteral administration, mupirocin is rapidly destroyed by non-specific esterases (possibly in renal or liver tissues since it is reasonably stable in blood) to inactive monic acid and its conjugates. It is strongly protein bound. About 0.25% is absorbed from intact skin. The skin ointment, but not the cream, contains polyethylene glycol, which may be absorbed significantly when applied to open wounds or damaged skin, including burns.

Clinical Use

Mupirocin is mainly used as a nasal cream as part of the regimen to decolonize patients who have been found to carry methicillin-resistant Staph. aureus. It can also be applied to tracheostomy, gastrostomy and other sites that are frequently colonized with MRSA.
The use of mupirocin as a means of controlling outbreaks of infection due to MRSA appears to be of only marginal benefit in an endemic situation.
A Cochrane Review of nine randomized controlled trials of use of mupirocin to prevent subsequent Staph. aureus infections in nasal carriers of the organism found a statistically significant reduction in such infections at any site. A small study of local therapy to reduce the risk of peritonitis in patients on continuous ambulatory peritoneal dialysis (CAPD) found that mupirocin applied three times weekly to the dialysis catheter exit site resulted in a 92% reduction in the rate of peritonitis

Side effects

Topical applications are well tolerated. Conjunctival application is contraindicated as it may cause irritation. Minor side effects such as irritation and unpleasant or abnormal taste have been recorded for very few patients following nasal application.
Polyethylene glycol from the ointment base may, if absorbed from application to open wounds or damaged skin, cause renal toxicity.

Mupirocin Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 533)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Jigs Chemical ltd +919099003427 Gujarat, India 239 58 Inquiry
PANCHSHEEL ORGANICS LTD +91-9821053955 +91-9324201019 Mumbai, India 82 58 Inquiry
Kawman Pharma (A Division of K P Manish Global Ingredients Pvt Ltd) +919043474090 Tamil Nadu, India 16 58 Inquiry
Horster Biotek Pvt Ltd +91-7359657360 +91-9898127219 Gujarat, India 58 58 Inquiry
Agro Cool India Ltd +91 9999464006 New Delhi, India 11 58 Inquiry
Fishfa Biogenics +91-9978999731 +91-9978910668 Gujarat, India 4 58 Inquiry
Humble Healthcare Limited +91-9720093000 +91-8006400378 Uttar Pradesh, India 141 58 Inquiry
Quad Lifesciences Pvt Ltd +91-9810034045 +91-9810034045 New Delhi, India 23 58 Inquiry
Concord Biotech Limited +91-2714398200 +91-2714398200 Gujarat, India 22 58 Inquiry
Bills Biotech Pvt Ltd +91-8980792545 +91-8238037545 Gujarat, India 4 58 Inquiry

Related articles

  • A naturally antibiotic:Mupirocin
  • Mupirocin, formerly called pseudomonic acid A, is a naturally occurring antibiotic that was originally isolated as a fermentat....
  • Mar 21,2022

Mupirocin Spectrum

MUPIROCIN L-talo-Non-2-enonic acid, 5,9-anhydro-2,3,4,8-tetradeoxy-8-(2S,3S)-3-(1S,2S)-2-hydroxy-1-methylpropyloxiranylmethyl-3-methyl-, 8-carboxyoctyl ester, (2E)- MUPIROCIN,USP Bactoderm Bactroban Ointment L-talo-Non-2-enonic acid, 5,9-anhydro-2,3,4,8-tetradeoxy-8-[[(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methylpropyl]oxiranyl]methyl]-3-methyl-, 8-carboxyoctyl ester, (2E)- (9CI) L-talo-Non-2-enonic acid, 5,9-anhydro-2,3,4,8-tetradeoxy-8-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-3-methyl-, 8-carboxyoctyl ester, [2E,8[2S,3S(1S,2S)]]- Turixin Mupirocin Hcl BRL 4910A, Pseudomonic acid, 5,9-Anhydro-2,3,4,8-tetradeoxy-8-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-3-methyl-[2E,8[2S,3S(1S,2S)]]-L-talonon-2-enonic acid 8-carboxyoctyl ester BRL-4910A:BactodelTn:Bactmban:Turixin Nonanoic acid, 9((3-methyl-1-oxo-4-(tetrahydro-3,4-dihydroxy-5-((3-(2-hydroxy-1-methylpropyl) oxiranyl)methyl)-2H-pyran-2-yl)-2-butenyl)oxy)-, (2S-(2-alpha(E),3-beta,4-beta,5- alpha(2R*,3R*(1R*,2R*)))) 9-[[(E)-3-Methyl-1-oxo-4-[(2S)-tetrahydro-3α,4α-dihydroxy-5β-[[(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methylpropyl]oxiran-2-yl]methyl]-2H-pyran-2-yl]-2-butenyl]oxy]nonanoic acid 9-[[(E)-3-Methyl-1-oxo-4-[(2S)-tetrahydro-3α,4α-dihydroxy-5β-[[(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methylpropyl]oxiran-2-yl]methyl]-2H-pyran-2β-yl]-2-butenyl]oxy]nonanoic acid (E)-13-{(2S,3R,4R,5S)-3,4-Dihydroxy-5-[(2S,3S)-3-((S)-2-hydroxy-1-methyl-propyl)-oxiranylmethyl]-tetrahydro-pyran-2-yl}-12-methyl-10-oxo-tridec-11-enoic acid 104486-81-9 (Calcium salt, anhydrous) 115074-43-6 (Calcium salt, dihydrate) Aids108090 Aids-108090 Mupirocin (50 mg) Mupirocin Neo-Sensitabs Mupricin Mupirocin(Bactroban) Mupirocin (GMP) Mupirocin, Bactroban, EisMycin, BRL 4910A, Y 11633 9-(((E)-4-((2S,3R,4R,5S)-3,4-dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)Methyl)tetrahydro-2H-pyran-2-yl)-3-Methylbut-2-enoyl)oxy)nonanoic acid (2s-(2-alpha(e 4-beta,5-alpha(2r*,3r*(1r*,2r*))))-3-beta nonanoicacid,9((3-methyl-1-oxo-4-(tetrahydro-3,4-dihydroxy-5-((3-(2-hydroxy-1 Mupirocin, Antibiotic for Culture Media Use Only 5,9-ANHYDRO-2,3,4,8-TETRADEOXY-8-[[3-(2-HYDROXY-1-METHYLPROPYL)OXIRANYL]METHYL]-3-METHYL-[2E,8[2S,3S(1S,2S)]]-L-TALONON-2-ENONIC ACID 8-CARBOXYOCTYL ESTER BRL 4910A MUPIROCIN, USP STANDARD MUPIROCIN, REFERENCE SPECTRUM EP STANDARD MUPIROCINE (2E)-5,9-Anhydro-2,3,4,8-tetradeoxy-8-[[(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methylpropyl]-oxiranyl]methyl]-3-methyl-L-talo-non-2-enonic Acid, 8-Carboxyoctyl Ester trans-pseudomonic Acid Turixi 9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3- [(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl] oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid Mupirocin/Mupirocin Calcium mupirocin calcium powder 9-[4-[3,4-dihydroxy-5-[[3-(3-hydroxybutan-2-yl)-2-oxiranyl]methyl]-2-oxanyl]-3-methyl-1-oxobut-2-enoxy]nonanoate MUPIROCIN OINTMENT    Mupirocin Acid Mupirocin USP/EP/BP Mupirocin (BRL-4910A) MupirocinQ: What is Mupirocin Q: What is the CAS Number of Mupirocin Q: What is the storage condition of Mupirocin Mupirocin API Mupirocin (1448901) MUPIROCIN CALCIUM bactroban PSEUDOMONIC ACID PSEUDOMONIC ACID A 231-791-2 Mupirocin Micronized Powder Mopirocin Mopiro Star 12650-69-0